Clincosm LogoSign in Get a demo

COVID-19

Showing NaN - NaN of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

Recruiting
  • COVID-19
  • +3 more
  • RQ-001
  • Placebo
  • Cullman, Alabama
  • +8 more
Sep 28, 2023

COVID-19, SARS-CoV-2 Trial in United States (VYD222, Normal saline)

Recruiting
  • COVID-19
  • SARS-CoV-2
  • Culver City, California
  • +15 more
Sep 8, 2023

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Denmark, United States (PF-07304814, Placebo, Remdesivir)

Suspended
  • COVID-19
  • Chula Vista, California
  • +39 more
Mar 22, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo)

Completed
Has Results
  • COVID-19
  • Jasper, Alabama
  • +102 more
Jan 14, 2023

SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),

Active, not recruiting
  • SARS-CoV2 Infection
  • +3 more
  • BNT162b2
  • +5 more
  • Long Beach, California
  • +34 more
Jan 10, 2023

COVID-19 Trial in Canada, Taiwan, United States (nirmatrelvir, ritonavir, for nirmatrelvir)

Recruiting
  • COVID-19
  • Mesa, Arizona
  • +43 more
Dec 29, 2022

COVID-19 Trial in United Kingdom, United States (AZD7442, Placebo)

Completed
Has Results
  • COVID-19
  • Guntersville, Alabama
  • +56 more
Oct 24, 2022

Infection Viral, Thromboses, Venous, COVID-19 Trial in United States (Enoxaparin Prefilled Syringe [Lovenox])

Completed
Has Results
  • Infection Viral
  • +2 more
  • Enoxaparin Prefilled Syringe [Lovenox]
  • Birmingham, Alabama
  • +15 more
Sep 15, 2022

COVID-19 Trial in Puerto Rico, United States (Convalescent Plasma, Masked Saline Placebo)

Terminated
Has Results
  • COVID-19
  • Convalescent Plasma
  • Masked Saline Placebo
  • Birmingham, Alabama
  • +23 more
Sep 9, 2022

SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

Completed
  • SARS-CoV Infection
  • +3 more
  • Moderna COVID-19 Vaccine
  • +2 more
  • Tucson, Arizona
  • +28 more
Sep 19, 2022

SARS-CoV-2 Infection, COVID-19, Maternal Immunization Trial in Worldwide (BNT162b2, Placebo)

Completed
  • SARS-CoV-2 Infection
  • +2 more
  • BNT162b2
  • Placebo
  • Birmingham, Alabama
  • +85 more
Aug 22, 2022

COVID-19 Trial in Worldwide (Remdesivir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +36 more
Aug 18, 2022

COVID-19, Endothelial Function Trial in Worldwide (Vascular occlusion test)

Recruiting
  • COVID-19
  • Endothelial Function
  • Vascular occlusion test
  • Dallas, Texas
  • +7 more
Jul 27, 2022

COVID-19 Trial in Worldwide (SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent), SARS-CoV-2 adjuvanted recombinant

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent)
  • +2 more
  • Birmingham, Alabama
  • +93 more
Jul 22, 2022

COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)

Completed
  • COVID-19
  • Lenzilumab
  • +2 more
  • Birmingham, Alabama
  • +55 more
Jul 21, 2022

COVID-19 Trial in United States (Danicopan, Placebo, Remdesivir)

Completed
  • COVID-19
  • Birmingham, Alabama
  • +38 more
Jul 21, 2022

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,

Terminated
  • 2019 Novel Coronavirus Disease
  • +11 more
  • Newport Beach, California
  • +14 more
Jul 20, 2022

COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

Active, not recruiting
Has Results
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • Placebo
  • Phoenix, Arizona
  • +83 more
Jul 13, 2022